Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study.

التفاصيل البيبلوغرافية
العنوان:	Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study.
المؤلفون:	Witlox WJA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC) , Maastricht , The Netherlands., Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC) , Maastricht , The Netherlands., Groen HJM; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen , Groningen , The Netherlands., Dingemans AM; Department of Pulmonology, Maastricht University Medical Center, GROW Research Institute , Maastricht , The Netherlands., Praag J; Department of Radiation Oncology, Erasmus University Medical Center , Rotterdam , The Netherlands., Belderbos J; Department of Radiation Oncology, Netherlands Cancer Institute (NKI) , Amsterdam , The Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute (NKI) , Amsterdam , The Netherlands., van Tinteren H; Department of Biometrics, Netherlands Cancer Institute (NKI) , Amsterdam , The Netherlands., Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC) , Maastricht , The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University , Maastricht , The Netherlands., De Ruysscher DKM; Department of Radiation Oncology (Maastro clinic), Maastricht University Medical Center, GROW Research Institute , Maastricht , The Netherlands.
المصدر:	Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Oct; Vol. 58 (10), pp. 1528-1531. Date of Electronic Publication: 2019 Jul 01.
نوع المنشور:	Letter
اللغة:	English
بيانات الدورية:	Publisher: Medical Journals Sweden AB Country of Publication: England NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
أسماء مطبوعة:	Publication: 2024- : [Uppsala, Sweden] : Medical Journals Sweden AB Original Publication: Stockholm, Sweden : Acta Oncologica, [1987-
مواضيع طبية MeSH:	Cranial Irradiation, Brain Neoplasms/prevention & control , Carcinoma, Non-Small-Cell Lung/prevention & control , Chemoradiotherapy/methods , Lung Neoplasms/*pathology, Age Factors ; Brain Neoplasms/epidemiology ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Carcinoma, Non-Small-Cell Lung/secondary ; Clinical Trials, Phase III as Topic ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/therapy ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Sex Factors ; Time Factors ; Treatment Outcome
تواريخ الأحداث:	Date Created: 20190702 Date Completed: 20200319 Latest Revision: 20200319
رمز التحديث:	20240513
DOI:	10.1080/0284186X.2019.1629016
PMID:	31256737
قاعدة البيانات:	MEDLINE

PDF full text from Publisher

الوصف
تدمد:	1651-226X
DOI:	10.1080/0284186X.2019.1629016